cascadeslots| Tevogen Bio soared more than 60% in pre-market investment of US$50 million

Gelonghui May 13| Biomedical company Tevogen Bio rose 60% in pre-marketcascadeslots.49%cascadeslots, report 1cascadeslots.58 dollars. on the messagecascadeslotsRecently, the company completed strategic investment, which will further accelerate the biopharmaceutical research and development process. The company said it has signed a binding investment agreement with an existing investor to secure up to $50 million in financing. The financing included a $36 million credit line and a $14 million private placement. Financing is expected to end at the end of the second quarter.